Article Text
Correction
Correction: A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer
Statistics from Altmetric.com
Rammensee H, Wiesmüller K, Chandran PA, et al. A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer. J Immuno Ther Cancer 2019;7:307. doi: 10.1186/s40425-019-0796-5.
In the article titled ‘A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer’, the author name Yamel Cardona Gloria is abbreviated incorrectly. The author’s first name is Yamel and the family name is Cardona Gloria. The correct abbreviation is Cardona Gloria Y.